UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000021177 |
|---|---|
| Receipt number | R000024418 |
| Scientific Title | Renin Observed with Added Dapagliflozin - an Evaluation under Unexceptional RAS Inhibitor Administration. |
| Date of disclosure of the study information | 2016/04/01 |
| Last modified on | 2019/04/16 09:06:33 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/02/24 14:54:02 | ||
| 2 | Update | 2016/04/22 14:04:50 | Acronym Acronym |
|
| 3 | Update | 2016/06/10 10:38:41 | Name of primary person or sponsor Organization |
|
| 4 | Update | 2016/06/10 16:57:49 | Key exclusion criteria |
|
| 5 | Update | 2016/06/16 13:20:32 | Primary outcomes Primary outcomes |
|
| 6 | Update | 2016/06/16 13:21:40 | Key inclusion criteria Key inclusion criteria Key exclusion criteria |
|
| 7 | Update | 2016/06/16 13:24:08 | Co-sponsor Co-sponsor Institutions |
|
| 8 | Update | 2016/07/04 19:26:13 | Anticipated trial start date |
|
| 9 | Update | 2016/07/05 16:42:21 | Recruitment status |
|
| 10 | Update | 2016/09/26 13:41:31 | Institutions |
|
| 11 | Update | 2017/05/31 13:03:05 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
| 12 | Update | 2017/05/31 13:12:46 | Institutions |
|
| 13 | Update | 2017/12/08 11:27:49 | Organization Organization Institutions |
|
| 14 | Update | 2018/02/26 11:16:16 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
| 15 | Update | 2018/08/27 10:43:55 | Recruitment status |
|
| 16 | Update | 2019/02/26 09:53:16 | Organization Organization Institutions |
|
| 17 | Update | 2019/03/27 10:46:02 | Number of participants that the trial has enrolled Results Results Results date posted |
|
| 18 | Update | 2019/03/27 10:48:11 | Recruitment status Date of IRB Last follow-up date |
|
| 19 | Update | 2019/04/16 09:06:33 | Results |
